CT Catapult to discuss bioengineered organs & T cell therapies at ISCT 2014

The Cell Therapy Catapult, which is focused on the development of the UK cell therapy industry to increase the nation’s health and wealth, will be discussing bioengineered replacement organs, the future of the industry and the potential of T cell therapies at ISCT 2014 next week. It will also be hosting an exhibition stand at the meeting, the 20th Anniversary International Society for Cellular Therapy conference1, which runs from April 23-25.

The Cell Therapy Catapult’s sessions are listed below.

22 April Trachea Satellite Meeting

Dr Natalie Mount, Cell Therapy Catapult Chief Clinical Officer – Navigating the regulatory environment to accelerate development of bioengineered tracheal replacement.

24 April Sponsor of industry networking reception

British Ambassador’s residence

25 April Plenary Session 4 – State of the Industry: Past, Present & Future Development

Matthew Durdy, Cell Therapy Catapult Chief Business Officer – Cell therapy: what will be different next time

26 April Technical Session 6 – T Cell Therapy: From Product Development to Immunomodulation

Dr Natalie Mount, Cell Therapy Catapult Chief Clinical Officer – Cytotoxic/effector T cell therapies: recent progress and future potential

Also next week, the Cell Therapy Catapult is presenting at the Stem Cell Summit2, which is taking place in Boston, USA, from April 23-25. Our session details are below.

25 April Conference B: Stem Cell Commercialisation & Partnering

Commercialisation – Bringing Therapeutics to Market

Professor Johan Hyllner, Cell Therapy Catapult Chief Scientific Officer

Please get in contact with us on info@ct.catapult.org.uk if you would like to meet us at either event.